Relevant to these results, since glycogen synthase kinase 3β (GSK3β) induces β-catenin degradation and glycogen synthase inactivation, note that glucose did not significantly change GSK3β activity in colon cancer cells, according to unchanged levels of pGSK3β (S9) as previously published [40]. The gene discussed is GSK3B; the disease is colonic neoplasm.